For example, SGN-CD48A, a humanized anti-CD48 mAb conjugated to monomethyl auristatin E, has demonstrated potent antitumor activity against a range of human MM cell lines in vitro, while having minimal effects on resting human B, NK, and T lymphocytes [95]. The gene discussed is CD48; the disease is Miyoshi myopathy.